Concord Drugs Share Price

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.

For the full year FY2025–2026, revenue reached ₹45.26 crore and profit touched at ₹0.34 crore.

As of 24 Jan 2026, Concord Drugs share price is ₹73. The stock opened at ₹74 and had closed at ₹74.2 the previous day. During today’s trading session, Concord Drugs share price moved between ₹71.00 and ₹74.10, with an average price for the day of ₹72.55. Over the last 52 weeks, the stock has recorded a low of ₹26.10 and a high of ₹92.52. In terms of performance, Concord Drugs share price has increased by 27.5% over the past six months and has increased by 95.93% over the last year.